| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/03/2011 | CN1997629B Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCR's) |
| 08/03/2011 | CN1964970B Iap的抑制剂 Iap inhibitors |
| 08/03/2011 | CN1917862B Dosage form that is safeguarded from abuse |
| 08/03/2011 | CN1898240B Imidazopyrazine tyrosine kinase inhibitors |
| 08/03/2011 | CN1891687B Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 08/03/2011 | CN1890218B Tubulin inhibitors |
| 08/03/2011 | CN1875002B Phenyl derivatives as PPAR agonists |
| 08/03/2011 | CN1863517B Rapidly disintegrating formulation |
| 08/03/2011 | CN1859917B Medicine and food/beverage for ameliorating hyperglycemia |
| 08/03/2011 | CN1850276B Taxol polymer bond drug lyophilized powder injection and its preparing method |
| 08/03/2011 | CN1849307B Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| 08/03/2011 | CN1784220B Use of effectors of glutaminyl and glutamate cyclases |
| 08/03/2011 | CN1729160B Drugs for chronic pain |
| 08/03/2011 | CN1720238B Neurologically-active compounds |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143967A Purification method for adefovir dipivoxil |
| 08/03/2011 | CN102143965A Pyrazolopyrimidines and their use for the treatment of CNS disorders |
| 08/03/2011 | CN102143963A Amides of diazabicyclooctanes and uses thereof |
| 08/03/2011 | CN102143962A Compounds having antiviral properties |
| 08/03/2011 | CN102143961A Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity |
| 08/03/2011 | CN102143959A Hepatitis c virus inhibitors |
| 08/03/2011 | CN102143958A Pyridazine derivatives as SMO inhibitors |
| 08/03/2011 | CN102143957A Benzimidazoles and related analogs as sirtuin modulators |
| 08/03/2011 | CN102143956A Derivatives of indole 2-carboxamides and azaindole 2-carboxamides substituted by a silanyle group, preparation thereof and therapeutic use thereof |
| 08/03/2011 | CN102143955A 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors |
| 08/03/2011 | CN102143953A Pyrimidines, triazines and their use as pharmaceutical agents |
| 08/03/2011 | CN102143951A Tri-substituted pyrimidine compounds and their use as PDE10 inhibitors |
| 08/03/2011 | CN102143949A 2-oxo-1,2-dihydro-quinoline modulators of immune function |
| 08/03/2011 | CN102143947A Novel inhibitors of proliferation and activation of signal transducer and activator of transcription (stats) |
| 08/03/2011 | CN102143946A Calcium ion channel modulators & uses thereof |
| 08/03/2011 | CN102143944A Organic compounds |
| 08/03/2011 | CN102143942A Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors |
| 08/03/2011 | CN102143940A Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists |
| 08/03/2011 | CN102143939A Solid states of aliskiren free base |
| 08/03/2011 | CN102143936A Platinum complex and medical compound containing same |
| 08/03/2011 | CN102143761A Agent for treating myelofibrosis |
| 08/03/2011 | CN102143754A Composition comprising crystallisation inhibitory substances |
| 08/03/2011 | CN102143753A Hair growth promoting agent containing 15,15-difluoroprostaglandin F2alpha derivative as active ingredient |
| 08/03/2011 | CN102143752A PDE10 inhibitors and related compositions and methods |
| 08/03/2011 | CN102143751A Use of rifalazil to treat colonic disorders |
| 08/03/2011 | CN102143750A Macrocyclics pyrimidines as aurora kinase inhibitors |
| 08/03/2011 | CN102143749A Methods and systems for evaluating memory agents |
| 08/03/2011 | CN102143748A Combination therapy for tuberculosis |
| 08/03/2011 | CN102143747A New pyridine derivatives as leptin receptor modulator mimetics |
| 08/03/2011 | CN102143746A CDK modulators |
| 08/03/2011 | CN102143745A Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 08/03/2011 | CN102143744A Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof |
| 08/03/2011 | CN102143743A Reducing cholesterol levels with combined use of querceting and statin |
| 08/03/2011 | CN102143742A Phosphate binding materials and their uses |
| 08/03/2011 | CN102143741A Uses of sesquiterpene derivatives |
| 08/03/2011 | CN102143740A Use of opioid antagonists for treating urinary retention |
| 08/03/2011 | CN102143739A Stable pharmaceutical composition for optimized delivery of an HIV attachment inhibitor |
| 08/03/2011 | CN102143737A Method for making cetirizine tablets |
| 08/03/2011 | CN102143687A Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions |
| 08/03/2011 | CN102140473A Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/03/2011 | CN102140460A SiRNA (Small interference ribonucleic acid) as well as medicine composition and pharmaceutical application thereof |
| 08/03/2011 | CN102140126A Rotundic acid derivative and synthesis method thereof as well as application of rotundic acid derivative in preparing medicament for preventing and curing cardiovascular disease |
| 08/03/2011 | CN102140125A Novel fusidic acid derivative, preparation method and medical application thereof |
| 08/03/2011 | CN102140104A 1-(3-(S)-amino propyl)-piperidine-4-aminoacid amide compound and pharmaceutical composition thereof as well as preparation methods and applications of compound and pharmaceutical composition |
| 08/03/2011 | CN102140101A Method for preparing Herperione, application thereof, capsule thereof, preparation method and application of capsule |
| 08/03/2011 | CN102140100A Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof |
| 08/03/2011 | CN102140099A Novel pyridine derivative |
| 08/03/2011 | CN102140098A 7-(2-substituted-3-amino-1-pyrrolidine[3, 4-c]pyrazolyl) quinoline carboxylic acid derivatives, preparation method thereof and application thereof in antibiosis and anti-tuberculosis |
| 08/03/2011 | CN102140093A Pyridine amide derivatives, preparation method thereof and application thereof in medicines |
| 08/03/2011 | CN102140092A Hydrate of ilaprazole salt, preparation method thereof and application thereof |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN102140081A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors |
| 08/03/2011 | CN102140079A Novel yunaconitine and preparation method thereof as well as pharmaceutical composition based on compound as active ingredient and application of novel yunaconitine |
| 08/03/2011 | CN102140066A Medicinal application of benzyl chloride tertiary amine dibromo antimicrobial compounds |
| 08/03/2011 | CN102140064A Compounds for the treatment of metabolic disorders |
| 08/03/2011 | CN102139111A Water-soluble matrix and application thereof in preparation of dithranol water-soluble preparations |
| 08/03/2011 | CN102139110A Use of angiotensin II receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 08/03/2011 | CN102139107A Anticancer effect of antagonist of neurokinin receptor |
| 08/03/2011 | CN102139079A Chinese medicinal gel for treating senile vaginitis and preparation method and application thereof |
| 08/03/2011 | CN102139059A Chinese medicinal composition for treating chloasma and preparation method thereof |
| 08/03/2011 | CN102139050A Chinese medicinal formula for treating dry cough |
| 08/03/2011 | CN102139048A Quality control method of tablet capable of improving eyesight and clearing heat |
| 08/03/2011 | CN102139045A Quality control method for Xiebai syrup |
| 08/03/2011 | CN102139030A Oral Chinese herbal preparation for treating gingivitis and preparation method thereof |
| 08/03/2011 | CN102139027A Medicinal liquor for treating rheumatic arthritis |
| 08/03/2011 | CN102139026A Nasal spray for treating apoplexy and preparation method thereof |
| 08/03/2011 | CN102139020A Medicament for treating influenza and bad cold and preparation method thereof |
| 08/03/2011 | CN102139004A Plaster for treating gout disease and application thereof |
| 08/03/2011 | CN102138993A Hyperosteogeny ointment |
| 08/03/2011 | CN102138989A Chinese medicinal ointment for treating scalding, and preparation method and application thereof |
| 08/03/2011 | CN102138970A Method for preparing compound salvia tablet |
| 08/03/2011 | CN102138942A Composite probiotics for prevention and adjuvant therapy of cancers and preparation method thereof |
| 08/03/2011 | CN102138934A Emulsifiable paste for treating scabies |
| 08/03/2011 | CN102138932A Buffered compositions for dialysis |
| 08/03/2011 | CN102138930A Solid preparation of compound sodium rabeprazole medicinal composition |
| 08/03/2011 | CN102138929A Surgical hemostat for pets and preparation method thereof |
| 08/03/2011 | CN102138928A Establishing method of hepatocyte apoptosis animal model and application thereof |
| 08/03/2011 | CN102138927A Chloroquine and adriamycin co-supported liposome and preparation method thereof |
| 08/03/2011 | CN102138926A Application of ginsenoside Rd to preparing anti-depression medicament |
| 08/03/2011 | CN102138925A Tigecycline composition and preparation method thereof |
| 08/03/2011 | CN102138924A Cefcapene pivoxil hydrochloride composition and preparation method thereof |
| 08/03/2011 | CN102138923A Cefcapene pivoxil hydrochloride composition and preparation method thereof |
| 08/03/2011 | CN102138922A Cefcapene pivoxil hydrochloride composition and preparation method thereof |
| 08/03/2011 | CN102138921A Application of phthalimide derivatives to preparation of anti-angiogenesis medicaments |
| 08/03/2011 | CN102138920A Medicinal composition containing candesartan cilexetil and hydrochlorothiazide and preparation method thereof |